These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9566104)

  • 41. Long-term application of disease modifying antirheumatic drugs (DMARD). A single-center, observational study of 1681 patients with rheumatoid arthritis (RA).
    Keysser M; Keysser G; Keysser C
    Z Rheumatol; 1999 Oct; 58(5):267-76. PubMed ID: 10591974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs--a multicenter, double-blind, parallel-group trial.
    Kawai S; Takeuchi T; Yamamoto K; Tanaka Y; Miyasaka N
    Mod Rheumatol; 2011 Oct; 21(5):458-68. PubMed ID: 21347803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Benefit and risk of methotrexate treatment in rheumatoid arthritis.
    Rau R; Herborn G
    Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S83-94. PubMed ID: 15552520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Methotrexate for therapy of rheumatoid arthritis].
    Suzuki Y; Wakabayashi T; Jackson K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():498-502. PubMed ID: 15799406
    [No Abstract]   [Full Text] [Related]  

  • 45. [Three joints swollen, blood sedimentation increased. Methotrexate to be given immediately?].
    Burmester GR
    MMW Fortschr Med; 2004 Sep; 146(37):10. PubMed ID: 15887693
    [No Abstract]   [Full Text] [Related]  

  • 46. Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.
    McInnes IB; Porter D; Murphy EA; Thomson EA; Madhok R; Hunter JA; Pullar T; Capell HA
    Ann Rheum Dis; 1996 May; 55(5):328-30. PubMed ID: 8660109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Summaries for patients. Adding low-dose prednisone to methotrexate therapy for early rheumatoid arthritis.
    Ann Intern Med; 2012 Mar; 156(5):I18. PubMed ID: 22393145
    [No Abstract]   [Full Text] [Related]  

  • 48. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone.
    Korthals-de Bos I; Van Tulder M; Boers M; Verhoeven AC; Adèr HJ; Bibo J; Boonen A; Van Der Linden S
    J Rheumatol; 2004 Sep; 31(9):1709-16. PubMed ID: 15338488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclosporine in addition to infliximab and methotrexate in refractory rheumatoid arthritis.
    Marchesoni A; Sarzi Puttini P; Gorla R; Caporali R; Arnoldi C; Atzeni F; Vianelli M; Pallavicini FB
    Clin Exp Rheumatol; 2005; 23(6):916-7. PubMed ID: 16396721
    [No Abstract]   [Full Text] [Related]  

  • 50. [Examination of the escape phenomenon in disease modifying antirheumatic drugs].
    Kawasaki Y; Moriyama M; Shibata K; Gomita Y
    Yakugaku Zasshi; 2005 Mar; 125(3):293-7. PubMed ID: 15738628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reducing methotrexate errors.
    Zarowitz BJ
    Geriatr Nurs; 2010; 31(5):361-4. PubMed ID: 20832909
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effectiveness of methotrexate for the escape by salazosulfapyridine].
    Kawasaki Y; Moriyama M; Shibata K; Gomita Y
    Yakugaku Zasshi; 2005 Jul; 125(7):579-82. PubMed ID: 15997214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current concepts in the management of rheumatoid arthritis.
    Murphy NG
    Del Med J; 1992 Apr; 64(4):257-64. PubMed ID: 1352263
    [No Abstract]   [Full Text] [Related]  

  • 54. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
    Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination therapy with cyclosporin in rheumatoid arthritis.
    Yocum DE
    Drugs; 1995; 50 Suppl 1():37-40. PubMed ID: 8714797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Combined administration of long-acting antirheumatic drugs in the treatment of chronic polyarthritis].
    Wollenhaupt J; Zeidler H
    Dtsch Med Wochenschr; 1997 Oct; 122(40):1219-23. PubMed ID: 9378046
    [No Abstract]   [Full Text] [Related]  

  • 58. [Leflunomide + methotrexate combination therapy from the physician's viewpoint].
    Reinhold-Keller E; Gromnica-Ihle E
    Z Rheumatol; 2002 Apr; 61(2):191-3. PubMed ID: 12056299
    [No Abstract]   [Full Text] [Related]  

  • 59. Therapies for active rheumatoid arthritis after methotrexate failure.
    O'Dell JR; Mikuls TR; Taylor TH; Ahluwalia V; Brophy M; Warren SR; Lew RA; Cannella AC; Kunkel G; Phibbs CS; Anis AH; Leatherman S; Keystone E;
    N Engl J Med; 2013 Jul; 369(4):307-18. PubMed ID: 23755969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.
    Möttönen T; Hannonen P; Korpela M; Nissilä M; Kautiainen H; Ilonen J; Laasonen L; Kaipiainen-Seppänen O; Franzen P; Helve T; Koski J; Gripenberg-Gahmberg M; Myllykangas-Luosujärvi R; Leirisalo-Repo M;
    Arthritis Rheum; 2002 Apr; 46(4):894-8. PubMed ID: 11953964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.